Search
for

    Glossary Teriflunomide

    medication used to treat multiple sclerosis by reducing immune activity

    Teriflunomide is a medication primarily used to treat multiple sclerosis (MS), a condition where the immune system attacks the protective covering of nerves. It works by inhibiting the function of certain immune cells, thereby reducing inflammation and the frequency of MS flare-ups.

    Research 10 of 33

    1. Teriflunomide and Its Mechanism of Action in Multiple Sclerosis Drugs · 2014 · 253 citations
    2. Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions Multiple Sclerosis and Related Disorders · 2015 · 72 citations
    3. Teriflunomide: A Once-daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis Clinical Therapeutics · 2015 · 39 citations
    4. Teriflunomide (Aubagio®) for the treatment of multiple sclerosis Experimental Neurology · 2014 · 36 citations
    5. Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis CNS drugs · 2016 · 29 citations
    6. Teriflunomide in multiple sclerosis: an update Neurodegenerative disease management · 2016 · 20 citations
    7. Teriflunomide: a novel oral treatment for relapsing multiple sclerosis Expert Opinion on Pharmacotherapy · 2014 · 16 citations
    8. “Nail loss after teriflunomide treatment: A new potential adverse event” Multiple Sclerosis and Related Disorders · 2017 · 6 citations
    9. Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice? Neurology and Therapy · 2018 · 5 citations
    10. Hair Loss Associated with Teriflunomide Treatment Journal of Multiple Sclerosis and Neuroimmunology · 2023
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →